Once-Daily Oral Dose of BeneFlax to Healthy Older Adults

Inclusion Criteria: * Male or female adult 60 to 80 years residing in Saskatoon. * Able to comply with study protocol. * Able to follow simple instructions. Exclusion Criteria: * Age below 60 or above 80 years at initiation of the study. * Individuals living in long term care homes. * Individuals at risk of hypotension or with symptomatic hypotension. * Fasting hypoglycemia. * Unstable diabetes, or diabetics taking insulin (note: eligible diabetic participants will undergo additional testing during the study). * Current cancer or diagnosed with cancer in the past 2 years. * Women with an immediate family history or personal history of breast cancer or ovarian cancer. * Significant liver or other gastrointestinal disorder including inflammatory bowel disease. (While constipation is the most common gastrointestinal problem in the elderly, it would not be a contraindication) * Significant kidney disorder. * Unstable or severe cardiac disease, recent myocardial infarction or stroke (either in past 6 months or significantly affecting physical mobility). * Unstable other medical disease including, but not limited to, pulmonary disorder, epilepsy and genitourinary disorder. * Migraine with aura within the last year (as this is a risk factor for stroke). * Current diagnosis of a bleeding condition, or at risk of bleeding. * Significant immunocompromise. * Other unstable conditions. * Current use of hormone replacement therapy (except thyroid medication is allowed). * Current use of warfarin, clopidogrel, ticlopidine, dipyridamole or their analogues. * Intolerances or allergies to flax or vitamin D. * Allergy to whey * Surgery within the last six months. * Participation in any other clinical trial with an investigational agent within one month prior to randomization.